Ignite Creation Date:
2024-05-06 @ 8:25 PM
Last Modification Date:
2024-10-26 @ 3:27 PM
Study NCT ID:
NCT06372717
Status:
RECRUITING
Last Update Posted:
2024-07-09
First Post:
2024-03-11
Brief Title:
A Study to Investigate APL-4098 Alone andor in Combination With Azacitidine in RR AML and High-Risk MDS
Sponsor:
Apollo Therapeutics Ltd
Organization:
Apollo Therapeutics Ltd
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Acute Myeloid Leukemia in Relapse |
| Acute Myeloid Leukemia Refractory |
| Myelodysplastic Syndrome Acute Myeloid Leukemia |
| Myelodysplastic Syndrome With Excess Blasts |
Keywords: